Posts

Showing posts with the label healthcare

Surgical Lamps Help Reduce the Risk of Accidental Injury or Loss of Blood and Illuminate a Surgical Field and Minimize the Chances of Postoperative Bleeding

Image
  Surgical lamps are used in the surgical theatre to illuminate a surgical field and minimize the chances of postoperative bleeding, general tissue damage, infection and other issues that can arise during surgery. A surgeon can switch on different lighting depending on the kind of surgery that is going to be performed. Surgical lamps are generally made up of several different components such as the surgical lamp body ring, the surgical ballast, the surgical headlight, the surgical torch and the surgical stem. All these different parts play an important role in making the surgical lamp and its supporting infrastructure fully functional. Surgical lamps can be used for many purposes depending on their main function. Some of the main functions of surgical lamps are to increase the safety and eliminate confusion in the surgical theatre. It is very important for the surgeon to make the surgical field as clear and lighted as possible to reduce the risk of accidental injury or loss of b...

Increasing Adoption of Facial Rejuvenation and Approval and Launch of New Products to Augment Growth of Facial Rejuvenation Market

Image
  Facial rejuvenation is basically a cosmetic procedure, which aims to bring about a more youthful look to the face. Facial rejuvenation may be achieved through both non-invasive and invasive methods. Non-invasive procedures can range from mild to highly invasive. These procedures have also evolved significantly over the past decade or so. More recently, non-invasive procedures have become popular options for achieving facial rejuvenation. Market Dynamics Approval and launch of new products is expected to propel growth of the facial rejuvenation market. For instance, in August 2020, Cutera, Inc. launched its new Fraxis PRO progressive dermal remodeling technology. Moreover, increasing adoption of facial rejuvenation is also expected to aid in growth of the market. For instance, according to International Society of Aesthetic Plastic Surgery, photo rejuvenation was one of the top five nonsurgical procedures for women and accounted for 347,305 procedures in 2019. Increasing ex...

The Emergence of COVID-19 to Augment Growth of the Outsourced Drug Discovery Market

Image
  With billions of dollars in research and development costs, pharmaceutical companies around the world are always looking for new ways to address their production processes in a cost-effective manner. One way to achieve this is through outsourcing drug discovery and development services. This type of service refers to the collaboration between small and large biotech and biotechnology companies to conduct research and development activities aimed at finding better solutions to the company's core chemical concerns. Outsourcing of these drug discovery services has enabled established pharmaceutical and biotechnology companies to focus on the development of new products that can bring about significant therapeutic change and provide tangible advantages to the company's shareholders. Contract research organizations manage almost all aspects of drug discovery. Market Dynamics I ncreasing demand for outsourcing analytical testing and clinical trial services, growing R&D ex...

Increasing Prevalence of Autoimmune Diseases to Augment the Remicade Biosimilars Market Growth

Image
  Biosimilar is a bio-therapeutic drug that is similar in terms of safety, quality, and efficacy to an existing therapeutic drug. Biosimilars are a class of therapeutic drugs that provide additional treatment options and help reduce healthcare costs. They are almost identical to an existing therapeutic drugs and can only be manufactured when the patent for the original innovator drug expires. Remicade biosimilars are used for the treatment of various autoimmune diseases such as ankylosing spondylitis, psoriatic arthritis, chronic severe plaque psoriasis, ulcerative colitis, Crohn's Disease, rheumatoid arthritis, etc. The number of biosimilars currently approved by the FDA is twenty-eight. Market Dynamics Increasing demand for biosimilar drugs and increasing incidence/prevalence of autoimmune diseases such as rheumatoid arthritis and plaque psoriasis is expected to propel the remicade biosimilar market growth. For instance, more than 24 people in the United States (more than ...